Periodic Reporting for period 1 - SweetCAR (CAR-T cell therapy targeting carbohydrates in cancer)

Major limitations in current immunotherapy success are low antigenicity of targeting antigen and tumor heterogeneity. Hence there is an unmet need for novel antigen targets that could potentially be expressed on many tumor types. Cancer express aberrant cell surface...